Covalon Technologies Ltd. (CVALF)
OTCMKTS · Delayed Price · Currency is USD
1.800
+0.060 (3.42%)
Aug 14, 2025, 9:30 AM EDT
Covalon Technologies Market Cap
Covalon Technologies has a market cap or net worth of $50.07 million as of August 14, 2025. Its market cap has increased by 29.59% in one year.
Market Cap
50.07M
Enterprise Value
37.44M
Revenue
23.55M
Ranking
n/a
PE Ratio
19.47
Stock Price
$1.80
Market Cap Chart
Since September 3, 2004, Covalon Technologies's market cap has increased from 2.36M to 50.07M, an increase of 2,026.07%. That is a compound annual growth rate of 15.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 47.80M | -22.77% |
| Dec 31, 2024 | 61.89M | 212.54% |
| Dec 29, 2023 | 19.80M | -54.51% |
| Dec 30, 2022 | 43.53M | -19.65% |
| Dec 31, 2021 | 54.17M | 132.47% |
| Dec 31, 2020 | 23.30M | -41.18% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.72M |
| Veradigm | 798.20M |
| Tian'an Technology Group | 628.15M |
| Glass House Brands | 597.56M |
| Elite Pharmaceuticals | 567.50M |
| Northwest Biotherapeutics | 349.08M |
| American Oncology Network | 337.45M |
| CytoDyn | 300.87M |